Effects of probiotics for the prevention and treatment of radiation-induced diarrhea

Journal of Clinical Gastroenterology

Volumn 43, Issue 6, 2009, Pages 506-513

  Fuccio, Lorenzo ^a   Guido, Alessandra ^a   Eusebi, Leonardo H ^a   Laterza, Liboria ^a   Grilli, Diego ^b   Cennamo, Vincenzo ^a   Ceroni, Liza ^a   Barbieri, Enza ^a   Bazzoli, Franco ^a,c  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b UNIVERSITY OF SOUTH FLORIDA   (United States)

^c UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

Diarrhea; Meta analysis; Prevention; Probiotics; Radiotherapy

Indexed keywords

CISPLATIN; DN 114 001; PLACEBO; PROBIOTIC AGENT; UNCLASSIFIED DRUG; VSL3;

ABDOMINAL TUMOR; ADVANCED CANCER; BIFIDOBACTERIUM BREVE; BIFIDOBACTERIUM LONGUM; BIFIDOBACTERIUM LONGUM INFANTIS; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CHEMOPROPHYLAXIS; CLINICAL TRIAL; COCHRANE LIBRARY; COLON CANCER; DIARRHEA; DIET RESTRICTION; DRUG EFFECT; DRUG EFFICACY; DRUG SAFETY; DRUG WITHDRAWAL; EMBASE; ENDOMETRIUM CARCINOMA; FECES ANALYSIS; GASTROINTESTINAL SYMPTOM; HUMAN; LACTOBACILLUS ACIDOPHILUS; LACTOBACILLUS CASEI; LACTOBACILLUS DELBRUECKII; LACTOBACILLUS PLANTARUM; MEDLINE; META ANALYSIS; OVARY CANCER; PELVIS TUMOR; PRIORITY JOURNAL; PROSTATE CANCER; RADIATION DOSE; RADIATION INDUCED DIARRHEA; RANDOMIZED CONTROLLED TRIAL; RECTUM CANCER; REVIEW; STREPTOCOCCUS THERMOPHILUS; SYSTEMATIC REVIEW; UTERINE CERVIX CANCER; UTERINE CERVIX CARCINOMA;

ANIMALS; DIARRHEA; DIETARY SUPPLEMENTS; HUMANS; LACTOBACILLUS; MALE; PROBIOTICS; RADIOTHERAPY; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RATS; RATS, WISTAR; TREATMENT OUTCOME;

EID: 67651087117     PISSN: 01920790     EISSN: None     Source Type: Journal    
DOI: 10.1097/MCG.0b013e3181a1f59c     Document Type: Review

References (54)

1. Danielsson A, Nyhlin H, Persson H, et al. Chronic diarrhoea after radiotherapy for gynaecological cancer: occurrence and aetiology. Gut. 1991;32:1180-1187.
2. Wang CJ, Leung SW, Chen HC, et al. The correlation of acute toxicity and late rectal injury in radiotherapy for cervical carcinoma: evidence suggestive of consequential late effect (CQLE). Int J Radiat Oncol Biol Phys. 1998;40:85-91.
3. Andreyev HJ, Vlavianos P, Blake P, et al. Gastrointestinal symptoms after pelvic radiotherapy: role for the gastroenterologist? Int J Radiat Oncol Biol Phys. 2005;62:1464-1471.
4. Ludgate SM, Merrick MV. The pathogenesis of post-irradiation chronic diarrhoea: measurement of SeHCAT and B12 absorption for differential diagnosis determines treatment. Clin Radiol. 1985;36:275-278.
5. Gami B, Harrington K, Blake P, et al. How patients manage gastrointestinal symptoms after pelvic radiotherapy. Aliment Pharmacol Ther. 2003;18:987-994.
6. Guarner F, Schaafsma GJ. Probiotics. Int J Food Microbiol. 1998;39:237-238.
7. Schrezenmeir J, De Vrese M. Probiotics, prebiotics, and synbiotics - approaching a definition. Am J Clin Nutr. 2001;73:361S-364S.
8. Demirer S, Aydintug S, Aslim B, et al. Effects of probiotics on radiation-induced intestinal injury in rats. Nutrition. 2006;22:179-186.
9. Seal M, Naito Y, Barreto R, et al. Experimental radiotherapyinduced enteritis: a probiotic interventional study. J Dig Dis. 2007;8:143-147.
10. Delia P, Sansotta G, Donato V, et al. Use of probiotics for prevention of radiation-induced diarrhea. World J Gastroenterol. 2007;13:912-915.
11. Giralt J, Regadera JP, Verges R, et al. Effects of probiotic Lactobacillus casei DN-114 001 in prevention of radiationinduced diarrhea: results from multicenter, randomized, placebo-controlled nutritional trial. Int J Radiat Oncol Biol Phys. 2008;71:1213-1219.
12. Urbancsek H, Kazar T, Mezes I, et al. Results of a doubleblind, randomized study to evaluate the efficacy and safety of Antibiophilus in patients with radiation-induced diarrhoea. Eur J Gastroenterol Hepatol. 2001;13:391-396.
13. Guarner F, Malagelada JR. Gut flora in health and disease. Lancet. 2003;361:512-519.
14. Manichanh C, Varela E, Martinez C, et al. The gut microbiota predispose to the pathophysiology of acute postradiotherapy diarrhea. Am J Gastroenterol. 2008;103:1754-1761.
15. Husebye E, Skar V, Hoverstad T, et al. Abnormal intestinal motor patterns explain enteric colonization with gram-negative bacilli in late radiation enteropathy. Gastroenterology. 1995;109:1078-1089.
16. Berg RD. Bacterial translocation from the gastrointestinal tract. Adv Exp Med Biol. 1999;473:11-30.
17. Summers RW, Glenn CE, Flatt AJ, et al. Radiation and indomethacin effects on morphology, prostaglandins, and motility in dog jejunum. Am J Physiol. 1991;261:G145-G151.
18. Riordan SM, McIver CJ, Thomas DH, et al. Luminal bacteria and small-intestinal permeability. Scand J Gastroenterol. 1997;32:556-563.
19. Quigley EM, Quera R. Small intestinal bacterial overgrowth: roles of antibiotics, prebiotics, and probiotics. Gastroenterology. 2006;130:S78-S90.
20. Crawford PA, Gordon JI. Microbial regulation of intestinal radiosensitivity. Proc Natl Acad Sci USA. 2005;102: 13254-13259.
21. Paris F, Fuks Z, Kang A, et al. Endothelial apoptosis as the primary lesion initiating intestinal radiation damage in mice. Science. 2001;293:293-297.
22. Weichselbaum RR. Bugging the intestinal response to radiation. Proc Natl Acad Sci USA. 2005;102:13363-13364.
23. Madsen K. Probiotics and the immune response. J Clin Gastroenterol. 2006;40:232-234.
24. Fedorak RN. Understanding why probiotic therapies can be effective in treating IBD. J Clin Gastroenterol. 2008;42(suppl 3 Pt 1):S111-S115.
25. Mengheri E. Health, probiotics, and inflammation. J Clin Gastroenterol. 2008;42(suppl 3 Pt 2):S177-S178.
26. Madsen K, Cornish A, Soper P, et al. Probiotic bacteria enhance murine and human intestinal epithelial barrier function. Gastroenterology. 2001;121:580-591.
27. McCarthy J, O'Mahony L, O'Callaghan L, et al. Double blind, placebo controlled trial of two probiotic strains in interleukin 10 knockout mice and mechanistic link with cytokine balance. Gut. 2003;52:975-980.
28. Sullivan A, Nord CE. Probiotics and gastrointestinal diseases. J Intern Med. 2005;257:78-92.
29. Moher D, Cook DJ, Eastwood S, et al. Improving the quality of reports of meta-analyses of randomised controlled trials: the QUOROM statement. Quality of reporting of metaanalyses. Lancet. 1999;354:1896-1900.
30. Greenland S. Meta-analysis. In: Rothman KJGS, ed. Modern Epidemiology. 2nd ed. Philadelphia: Lippincot-Raven; 1998.
31. Juni P, Altman DG, Egger M. Systematic reviews in health care: assessing the quality of controlled clinical trials. BMJ. 2001;323:42-46.
32. Mantel N, Haenszel W. Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst. 1959;22:719-748.
33. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986;7:177-188.
34. Begg CB, Mazumdar M. Operating characteristics of a rank correlation test for publication bias. Biometrics. 1994;50:1088-1101.
35. Egger M, Davey Smith G, Schneider M, et al. Bias in metaanalysis detected by a simple, graphical test. BMJ. 1997;315:629-634.
36. Hedges LV, Olkin I. Statistical Methods for Meta-Analysis. San Diego, CA: Academic Pr; 1985.
37. Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med. 2002;21:1539-1558.
38. Higgins JP, Thompson SG, Deeks JJ, et al. Measuring inconsistency in meta-analyses. BMJ. 2003;327:557-560.
39. Delia P, Sansotta G, Donato V, et al. Prevention of radiationinduced diarrhea with the use of VSL#3, a new high-potency probiotic preparation. Am J Gastroenterol. 2002;97:2150-2152.
40. Delia P, Sansotta G, Donato V, et al. Prophylaxis of diarrhoea in patients submitted to radiotherapeutic treatment on pelvic district: personal experience. Dig Liver Dis. 2002;34(suppl 2):S84-S86.
41. Delia P, Sansotta G, Donato V, et al. Use of probiotics for prevention of radiation-induced diarrhea. Tumori. 2007;93(suppl):1-6.
42. Henriksson R, Franzen L, Sandstrom K, et al. Effects of active addition of bacterial cultures in fermented milk to patients with chronic bowel discomfort following irradiation. Support Care Cancer. 1995;3:81-83.
43. Salminen E, Elomaa I, Minkkinen J, et al. Preservation of intestinal integrity during radiotherapy using live Lactobacillus acidophilus cultures. Clin Radiol. 1988;39:435-437.
44. O'Donnell LJ, Virjee J, Heaton KW. Detection of pseudodiarrhoea by simple clinical assessment of intestinal transit rate. BMJ. 1990;300:439-440.
45. Sutton A, Abrams K, Jones D, et al. Methods for Meta-analysis in Medical Research. London: Wiley; 2000.
46. Petitti DB. Approaches to heterogeneity in meta-analysis. Stat Med. 2001;20:3625-3633.
47. Huedo-Medina TB, Sanchez-Meca J, Marin-Martinez F, et al. Assessing heterogeneity in meta-analysis: Q statistic or I2 index? Psychol Methods. 2006;11:193-206.
48. Higgins J, Green S. Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.0 [updated February 2008], chapter 10. The Cochrane Collaboration, 2008. Available at: http://www.cochrane-handbook.org.
49. Herbert RD, Bo K. Analysis of quality of interventions in systematic reviews. BMJ. 2005;331:507-509. (Pubitemid 41248136)
50. Schulz KF, Chalmers I, Hayes RJ, et al. Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials. JAMA. 1995;273: 408-412.
51. Moher D, Pham B, Jones A, et al. Does quality of reports of randomised trials affect estimates of intervention efficacy reported in meta-analyses? Lancet. 1998;352:609-613.
52. Begg C, Cho M, Eastwood S, et al. Improving the quality of reporting of randomized controlled trials. The CONSORT statement. JAMA. 1996;276:637-639.
53. Altman DG. Practical Statistics for Medical Research. London: Chapman and Hall; 1991.
54. Andreyev J. Gastrointestinal complications of pelvic radiotherapy: are they of any importance? Gut. 2005;54: 1051-1054.